ZIOPHARM ONCOLOGY INC

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

Entry into a Material Definitive Agreement

Material Modifications to Rights of Security Holders

Other Events

Other Events

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Other Events

Termination of a Material Definitive Agreement

Other Events

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Material Modifications to Rights of Security Holders

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 (amendment)

Registration (IPO) statement under Securities Act of 1933

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

06b

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Weis Holger

Postma Robert W

Vieser Jaime

Weis Holger

Jerman Michael Allen

Weis Holger

Weis Holger

Weis Holger

Postma Robert W

Jerman Michael Allen

Vieser Jaime

Price Adrian

Price Adrian

Postma Robert W

Jerman Michael Allen

Vieser Jaime

Price Adrian

Jerman Michael Allen

Postma Robert W

Vieser Jaime

No description available

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

No description available

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available